Terumo Blood and Cell Technologies
Terumo Blood and Cell Technologies is a global leader in medical technology, specializing in blood and cell-based therapies. With over 7,900 team members, the company is dedicated to advancing healthcare by providing innovative solutions for blood collection, processing, and storage. Their mission is to empower healthcare providers with the tools and insights needed to deliver high-quality care to patients worldwide. Terumo BCT is committed to unlocking the potential of blood and cells, offering a range of products and services that support lifesaving transfusions and next-generation therapies for diseases like cancer. The company is part of the Terumo Group, which has been contributing to society through healthcare for over a century.
Terumo Blood and Cell Technologies
10811 West Collins Ave., Lakewood, CO 80215, USA
What We Do
A suite of training, data insight, service, and consulting solutions designed to help blood and cell businesses reach their goals.
Comprehensive solutions for therapeutic apheresis, including cell collection and processing, supported by the Spectra Optia Apheresis System.
Software and services designed to help blood centers optimize data collection, analysis, and decision-making.
A versatile apheresis platform that collects high-quality blood components in any combination with a single-needle procedure.
An advanced system that automates the processing of whole blood into components like platelets in a single centrifugation cycle.
A system that reduces pathogen load in donated blood and inactivates residual white blood cells to enhance blood safety.
Application Area
Show More (2)Battlefield Resuscitation
Key People
President and Chief Executive Officer
Executive Vice President and Chief Financial Officer
General Manager, Plasma Innovations
General Manager, Global Therapy Innovations
Vice President, Enterprise Strategy
Senior Vice President, Global Research and Development
Vice President, Global Regulatory Affairs and Labeling
Senior Vice President, Human Resources
General Manager, Global Blood Solutions
Vice President, Global Quality
Senior Vice President, Global Commercial
Vice President, Digital Transformation
Senior Vice President, Global Manufacturing
News & Updates
Terumo Blood and Cell Technologies is working with the National Alliance of Sickle Cell Centers to improve outcomes for patients with Sickle Cell Disease.
Carter BloodCare has completed the transition to automated whole blood processing with Terumo Blood and Cell Technologies.
Terumo Blood and Cell Technologies and Akron Bio completed a study on MSC expansion using the Quantum Flex platform.